Polyethylene Glycol 3350 Nf Pegylax

Polyethylene Glycol 3350 Nf Pegylax

Polyethylene Glycol 3350 Nf Pegylax Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Patients with symptoms suggestive of bowel obstruction (nausea, vomiting, abdominal pain or distention) should be evaluated to rule out this condition before initiating Polyethylene Glycol 3350 NF therapy.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

For the treatment of occasional constipation. This product should be used for 2 weeks or less as directed by a physician.

History

There is currently no drug history available for this drug.

Other Information

A white powder for reconstitution. Polyethylene Glycol 3350 (Polyethylene Glycol 3350 Powder For Oral Solution) is a synthetic polyglycol having an average molecular weight of 3350. The actual molecular weight is not less than 90.0 percent and not greater than 110.0 percent of the normal  value. The chemical formula is HO(C2H4O)nH in which n represents the average number of ethylene groups. Below 55°  it is a free flowing white powder freely soluble in water. Polyethylene Glycol 3350 NF is an osmotic agent for the treatment of constipation.

Polyethylene Glycol 3350 Nf Pegylax Manufacturers


  • Martin Ekwealor Pharmaceuticals, Inc.
    Polyethylene Glycol 3350 Nf Pegylax (Polyethylene Glycol 3350) Powder, For Solution [Martin Ekwealor Pharmaceuticals, Inc.]

Login To Your Free Account